Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Journal article
Schilling WHK. et al, (2024), PLoS medicine, 21
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever.
Journal article
Ding J. et al, (2024), CPT: pharmacometrics & systems pharmacology
Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections.
Journal article
Ding J. et al, (2024), CPT: pharmacometrics & systems pharmacology
Determination of ivermectin in plasma and whole blood using LC-MS/MS
Journal article
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
A pharmacokinetic randomised interventional study to optimise dihydroartemisinin-piperaquine dosing for malaria preventive treatment in Malawian infants: A protocol for the OPTIMAL study
Journal article
Banda CG. et al, (2024), Wellcome Open Research, 9, 291 - 291
Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques
Journal article
Vanachayangkul P. et al, (2024), Antimicrobial Agents and Chemotherapy
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Journal article
Wattanakul T. et al, (2024), Nature Communications, 15
Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
Journal article
Saito M. et al, (2024), Antimicrobial Agents and Chemotherapy, 68
Determination of ivermectin in plasma and whole blood using LC-MS/MS
Journal article
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
Medication adherence framework: A population‐based pharmacokinetic approach and its application in antimalarial treatment assessments
Journal article
Ding J. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology
Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
Preprint
Chan XHS. et al, (2024)
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Journal article
Watson JA. et al, (2024), eLife, 13
Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine and chloroquine in Rhesus Macaques
Preprint
Vanachayangkul P. et al, (2024)
A high-throughput LC-MS/MS assay for piperaquine from dried blood spots: Improving malaria treatment in resource-limited settings.
Journal article
Blessborn D. et al, (2024), Journal of mass spectrometry and advances in the clinical lab, 31, 19 - 26
Use of population pharmacokinetic-pharmacodynamic modelling to inform antimalarial dose optimisation in infants
Preprint
Banda C. et al, (2023)
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
Journal article
Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance.
Journal article
Cavany S. et al, (2023), Nature communications, 14
Evidence based optimal dosing of intravenous artesunate in children with severe falciparum malaria
Journal article
Haghiri A. et al, (2023), Clinical Pharmacology & Therapeutics
Clinical needs assessment to inform development of a new assay to detect antimalarial drugs in patient samples: A case study
Journal article
Coonahan ES. et al, (2023), PLOS Global Public Health, 3, e0002087 - e0002087